Delivery Order SPE2DB20D2014-SPE2DB24FC00C
Award Date
5/23/24
Potential Completion Date
5/24/24
Potential Value
$1.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $3,531.46 delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 23, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by DLA Troop Support Medical...
This federal contract award is a delivery order valued at $2,426.43 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a period of performance through October 25, 2024. The award was made by the Defense Logistics Agency (DLA), a defense agency, and is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This is a $14,426.64 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product, with a completion date of February 7, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract...
This federal contract award is a Firm Fixed Price Delivery Order for $1,769.04 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of GVOKE PFS 1-PK 1 MG/0.2 ML SYR 0.2ML, a medical product, to support military healthcare programs. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026. This IDC serves as a primary...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,384.57 firm fixed-price delivery order is for GVOKE HYPOPEN 2PK 0.5MG/0.1 ML 0.1ML medical devices, with a completion date of February 25, 2025. The contract is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as...
This federal contract award is for $1,031.85 and was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is a delivery order for the procurement of GVOKE HYPOPEN 1-PK 1 MG/0.2 ML 0.2ML, a pharmaceutical product. The contract has an ultimate completion date of August 19, 2024. AmerisourceBergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including to military treatment facilities, veterans'...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,971.54, is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. The contract has a firm fixed price pricing type and runs through January 27, 2025. There is no set-aside designation for this award. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop...
This federal contract award, SPE2DB20D3103|SPE2DB25FN0V5, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,540.58 firm fixed-price delivery order is for the supply of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML, a medical product. The contract has an ultimate completion date of March 17, 2025 and was awarded on March 14, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite...
This federal contract award is for the delivery of GVOKE HYPOPEN 2-PK 1 MG/0.2 ML 0.2ML medical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $17,178.74 and a completion date of December 10, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a for-profit organization...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, is a Firm Fixed Price delivery order valued at $1,411.75 for the provision of pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has an ultimate completion date of March 14, 2023. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued at up...